Latvia vs United Kingdom of Great Britain and Northern Ireland: Share of E. coli infections resistant to cephalosporins
Latvia
16.2%
in 2022
United Kingdom of Great Britain and Northern Ireland
11.4%
in 2022
Latvia rank
34th
United Kingdom of Great Britain and Northern Ireland rank
37th
Share of E. coli infections resistant to cephalosporins over time
- Latvia
- United Kingdom of Great Britain and Northern Ireland
How they compare
Latvia currently reports 16.2% against 11.4% in United Kingdom of Great Britain and Northern Ireland, a difference of 4.8%.
That makes Latvia's figure about 1.4 times United Kingdom of Great Britain and Northern Ireland's.
Across all 6 years both countries report, Latvia has been ahead every year.
Latvia ranks 34th and United Kingdom of Great Britain and Northern Ireland ranks 37th of 46 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 18.8% | 10.8% | 8.0% | Latvia |
| 2020s | 22.8% | 10.8% | 12.0% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Latvia or United Kingdom of Great Britain and Northern Ireland?
- Latvia, at 16.2% against 11.4% in United Kingdom of Great Britain and Northern Ireland as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Latvia and United Kingdom of Great Britain and Northern Ireland?
- 4.8%, with Latvia ahead.
- How many years of comparable data are there for Latvia and United Kingdom of Great Britain and Northern Ireland?
- 6 years are reported by both, from 2017 to 2022.
- How do Latvia and United Kingdom of Great Britain and Northern Ireland rank globally for share of e. coli infections resistant to cephalosporins?
- Latvia ranks 34th and United Kingdom of Great Britain and Northern Ireland ranks 37th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).